Thymosin α1: a novel therapeutic option
Thymosin α1: a novel therapeutic option for patients with refractory chronic purulent rhinosinusitis
✍
Dalm, Virgil A.S.H.; de Wit, Harm; Drexhage, Hemmo A.
📂
Article
📅
2012
🏛
John Wiley and Sons
🌐
English
⚖ 553 KB